ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer

Activation of cancer stem cell signaling is central to acquired resistance to therapy in esophageal cancer (EC). ABT-263, a potent Bcl-2 family inhibitor, is active against many tumor types. However, effect of ABT-263 on EC cells and their resistant counterparts are unknown. Here we report that ABT-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiongrong, Song, Shumei, Wei, Shaozhong, Liu, Bin, Honjo, Soichiro, Scott, Ailing, Jin, Jiankang, Ma, Lang, Zhu, Haitao, Skinner, Heath D., Johnson, Randy L., Ajani, Jaffer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694873/
https://www.ncbi.nlm.nih.gov/pubmed/26317542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694873/
https://www.ncbi.nlm.nih.gov/pubmed/26317542

Ejemplares similares